Keyphrases
Current Treatment
100%
Relapsed or Refractory
100%
Pediatric Acute Lymphoblastic Leukemia
100%
Relapsed or Refractory Acute Myeloid Leukemia
100%
Emerging Treatments
100%
Pediatric
20%
Chemotherapy
20%
Patient's Will
20%
Acute Lymphoblastic Leukemia
20%
New Drugs
20%
Poor Prognosis
20%
Clinical High Risk
20%
Newly Diagnosed
20%
Remission
20%
Child Outcomes
20%
Prognostic Factors
20%
Hematopoietic Stem Cell Transplantation
20%
Cross-resistance
20%
Chemotherapy Protocols
20%
Chemotherapy Alone
20%
Second Complete Remission
20%
Adis
20%
Medicine and Dentistry
Emerging Treatment
100%
Acute Lymphoblastic Leukemia
100%
Pediatrics
100%
Chemotherapy
42%
Hematopoietic Stem Cell Transplantation
14%
Prognostic Factor
14%
Cross Resistance
14%
Clinician
14%
Immunology and Microbiology
Cross-Resistance
100%
Hematopoietic Stem Cell Transplantation
100%
Pharmacology, Toxicology and Pharmaceutical Science
Acute Lymphoblastic Leukemia
100%
Chemotherapy
42%
Remission
28%
Cross-Resistance
14%
Nursing and Health Professions
Acute Lymphoblastic Leukemia
100%
Remission
28%
Hematopoietic Stem Cell Transplantation
14%